000 03630nam a22003858i 4500
001 CR9780511975363
003 UkCbUP
005 20200124160244.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 101011s2011||||enk o ||1 0|eng|d
020 _a9780511975363 (ebook)
020 _z9780521829014 (hardback)
040 _aUkCbUP
_beng
_erda
_cUkCbUP
050 0 0 _aRC365
_b.Q35 2011
082 0 0 _a616.8/0471
_222
245 0 0 _aQuality of life measurement in neurodegenerative and related conditions /
_cedited by Crispin Jenkinson, Michele Peters, Mark B. Bromberg.
246 3 _aQuality of Life Measurement in Neurodegenerative & Related Conditions
264 1 _aCambridge :
_bCambridge University Press,
_c2011.
300 _a1 online resource (xii, 194 pages) :
_bdigital, PDF file(s).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
505 0 _aAspects of methodology relevant to patient-reported outcome measures (PROMs) -- Development and validation of the Parkinson's disease questionnaire and related measures -- Multiple sclerosis impact scale (MSIS-29): initial development, subsequent revision, lessons learned -- Patient-reported outcome measurement in motor neuron disease/amyotrophic lateral sclerosis: the ALSAQ and ALSAQ-5 -- Measuring quality of life in progressive supranuclear palsy: the PSP-QoL -- Measuring quality of life in multiple system atrophy -- Health-related quality of life in Huntington's disease -- Measuring quality of life in dementia -- Condition-specific instruments to measure the quality of life (QoL) of children and adolescents with cerebral palsy (CP) -- Outcome measures for informal carers of individuals with neurodegenerative conditions -- Translating patient-reported outcome measures (PROMs) for cross-cultural studies -- Rasch analysis -- Method for inputting missing questionnaire data -- Individualized quality of life measurement in neurodegenerative disorders.
520 _aPatient reported outcome measures are central to the evaluation of medical care and treatment regimes. Such measures depart from traditional clinical assessments as they are based on issues known to be of importance to patients. This book outlines the development and application of a variety of such measures in a wide range of neurological conditions. Introductory chapters outline issues in the application and validation of quality-of-life measures in neurology. Subsequent chapters survey the most widely used quality-of-life instruments in Parkinson's disease, motor neurone disease, multiple sclerosis, multiple system atrophy, progressive supranuclear palsy, and Alzheimer's/dementia. A chapter on cerebral palsy deals with the particular challenges to developing outcome measures for children. The book also addresses issues relating to the translation of measures for use in cross-cultural studies, handling missing data, carer experiences of long-term conditions, and methodological challenges. Essential reading for clinicians and researchers working in the field of neurology.
650 0 _aNervous system
_xDegeneration
_xPatients
_xRehabilitation.
650 0 _aOutcome assessment (Medical care)
650 0 _aQuality of life
_xMeasurement.
700 1 _aJenkinson, Crispin,
_d1962-
_eeditor.
700 1 _aPeters, Michele,
_cPh.D,
_eeditor.
700 1 _aBromberg, M. B.
_q(Mark B.),
_eeditor.
776 0 8 _iPrint version:
_z9780521829014
856 4 0 _uhttps://doi.org/10.1017/CBO9780511975363
999 _c518778
_d518776